International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women.
Parish SJ, Simon JA, Davis SR, Giraldi A, Goldstein I, Goldstein SW, Kim NN, Kingsberg SA, Morgentaler A, Nappi RE, Park K, Stuenkel CA, Traish AM, Vignozzi L.
J Sex Med. 2021 May;18(5):849-867. doi: 10.1016/j.jsxm.2020.10.009. Epub 2021 Apr 1.
The clinical management of testosterone replacement therapy in postmenopausal women with hypoactive sexual desire disorder: a review.
Uloko M, Rahman F, Puri LI, Rubin RS.
Int J Impot Res. 2022 Nov;34(7):635-641. doi: 10.1038/s41443-022-00613-0. Epub 2022 Oct 5.
Hypoactive Sexual Desire Disorder: International Society for the Study of Women's Sexual Health (ISSWSH) Expert Consensus Panel Review.
Goldstein I, Kim NN, Clayton AH, DeRogatis LR, Giraldi A, Parish SJ, Pfaus J, Simon JA, Kingsberg SA, Meston C, Stahl SM, Wallen K, Worsley R.
Mayo Clin Proc. 2017 Jan;92(1):114-128. doi: 10.1016/j.mayocp.2016.09.018. Epub 2016 Dec 1.
Testosterone use for hypoactive sexual desire disorder in postmenopausal women.
Parish SJ, Kling JM.
Menopause. 2023 Jul 1;30(7):781-783. doi: 10.1097/GME.0000000000002190. Epub 2023 Jun 13.
Hypoactive sexual desire disorder.
Davison SL.
Curr Opin Obstet Gynecol. 2012 Aug;24(4):215-20. doi: 10.1097/GCO.0b013e328355847e.
Hypoactive Sexual Desire Disorder: A Review of Epidemiology, Biopsychology, Diagnosis, and Treatment.
Parish SJ, Hahn SR.
Sex Med Rev. 2016 Apr;4(2):103-120. doi: 10.1016/j.sxmr.2015.11.009. Epub 2016 Feb 6.
Management of hypoactive sexual desire disorder in transgender women: a guide for clinicians.
Cocchetti C, Ristori J, Mazzoli F, Vignozzi L, Maggi M, Fisher AD.
Int J Impot Res. 2020 Nov;33(7):703-709. doi: 10.1038/s41443-021-00409-8. Epub 2021 Feb 8.
Medical Treatment of Female Sexual Dysfunction.
Nappi RE, Tiranini L, Martini E, Bosoni D, Righi A, Cucinella L.
Urol Clin North Am. 2022 May;49(2):299-307. doi: 10.1016/j.ucl.2022.02.001.
FDA Decisions on Measures of Hypoactive Sexual Desire Disorder in Women: A History, With Grounds to Consider Clinical Judgment.
Pyke RE.
Sex Med Rev. 2021 Apr;9(2):186-193. doi: 10.1016/j.sxmr.2020.12.001. Epub 2021 Jan 27.
An evaluation of bremelanotide injection for the treatment of hypoactive sexual desire disorder.
Cipriani S, Alfaroli C, Maseroli E, Vignozzi L.
Expert Opin Pharmacother. 2023 Jan;24(1):15-21. doi: 10.1080/14656566.2022.2132144. Epub 2022 Oct 18.
